Drug Profile
Research programme: interleukin 12 variants - GenOdyssee
Alternative Names: GOIL-12s; IL-12 variants - GenOdyssee; interleukin 12 variants - GenOdysseeLatest Information Update: 15 Oct 2021
Price :
$50
*
At a glance
- Originator GenOdyssee
- Class Adjuvants; Immunotherapies; Interleukins
- Mechanism of Action Interleukin 12 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections; Cancer; Parasitic infections; Viral infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in France
- 16 Jul 2016 No recent reports of development identified for preclinical development in Parasitic-infections in France